Ge Healthcare Technologies Stock Current Valuation
| GEHC Stock | 81.49 0.32 0.39% |
Valuation analysis of GE HealthCare Techno helps investors to measure GE HealthCare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of March 23, 2025, Enterprise Value Over EBITDA is expected to decline to 7.62. In addition to that, Enterprise Value Multiple is expected to decline to 7.62. Fundamental drivers impacting GE HealthCare's valuation include:
Fairly Valued
Today
Please note that GE HealthCare's price fluctuation is very steady at this time. Calculation of the real value of GE HealthCare Techno is based on 3 months time horizon. Increasing GE HealthCare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since GE HealthCare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GEHC Stock. However, GE HealthCare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 81.49 | Real 83.65 | Target 96.76 | Hype 81.49 | Naive 81.52 |
The real value of GEHC Stock, also known as its intrinsic value, is the underlying worth of GE HealthCare Techno Company, which is reflected in its stock price. It is based on GE HealthCare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of GE HealthCare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of GE HealthCare Technologies helps investors to forecast how GEHC stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GE HealthCare more accurately as focusing exclusively on GE HealthCare's fundamentals will not take into account other important factors: GE HealthCare Technologies Company Current Valuation Analysis
GE HealthCare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current GE HealthCare Current Valuation | 43.75 B |
Most of GE HealthCare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GE HealthCare Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
GEHC Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for GE HealthCare is extremely important. It helps to project a fair market value of GEHC Stock properly, considering its historical fundamentals such as Current Valuation. Since GE HealthCare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GE HealthCare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GE HealthCare's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, GE HealthCare Technologies has a Current Valuation of 43.75 B. This is 204.62% higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 163.19% lower than that of the firm.
GEHC Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GE HealthCare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GE HealthCare could also be used in its relative valuation, which is a method of valuing GE HealthCare by comparing valuation metrics of similar companies.GE HealthCare is currently under evaluation in current valuation category among its peers.
GE HealthCare ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, GE HealthCare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to GE HealthCare's managers, analysts, and investors.Environmental | Governance | Social |
GEHC Fundamentals
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.0577 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 43.75 B | ||||
| Shares Outstanding | 457.3 M | ||||
| Shares Owned By Insiders | 0.20 % | ||||
| Shares Owned By Institutions | 88.41 % | ||||
| Number Of Shares Shorted | 9.24 M | ||||
| Price To Book | 4.41 X | ||||
| Price To Sales | 1.89 X | ||||
| Revenue | 19.67 B | ||||
| Gross Profit | 8.21 B | ||||
| EBITDA | 3.67 B | ||||
| Net Income | 2.05 B | ||||
| Total Debt | 1.5 B | ||||
| Book Value Per Share | 18.48 X | ||||
| Cash Flow From Operations | 1.95 B | ||||
| Short Ratio | 3.52 X | ||||
| Earnings Per Share | 4.34 X | ||||
| Price To Earnings To Growth | 2.14 X | ||||
| Target Price | 100.99 | ||||
| Number Of Employees | 53 K | ||||
| Beta | 1.32 | ||||
| Market Capitalization | 37.27 B | ||||
| Total Asset | 33.09 B | ||||
| Retained Earnings | 3.26 B | ||||
| Working Capital | 348 M | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 33.09 B | ||||
| Last Dividend Paid | 0.13 |
About GE HealthCare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GE HealthCare Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GE HealthCare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GE HealthCare Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out GE HealthCare Piotroski F Score and GE HealthCare Altman Z Score analysis. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GE HealthCare. If investors know GEHC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GE HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.784 | Dividend Share 0.125 | Earnings Share 4.34 | Revenue Per Share | Quarterly Revenue Growth 0.022 |
The market value of GE HealthCare Techno is measured differently than its book value, which is the value of GEHC that is recorded on the company's balance sheet. Investors also form their own opinion of GE HealthCare's value that differs from its market value or its book value, called intrinsic value, which is GE HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GE HealthCare's market value can be influenced by many factors that don't directly affect GE HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GE HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if GE HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GE HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.